Targeting CCNE1 amplified ovarian and endometrial cancers by combined inhibition of PKMYT1 and ATR
Fiona Simpkins(University of Pennsylvania Health System), Gary S. Marshall(University of Louisville)
Cited by 3
Related Papers
Targeting the ATR/CHK1 Axis with PARP Inhibition Results in Tumor Regression in <i>BRCA</i> -Mutant Ovarian Cancer Models
|Clinical Cancer Research|2016|292
A patient-derived-xenograft platform to study BRCA-deficient ovarian cancers
|JCI Insight|2017|71